WHO ICTRP trial
5 days a week versus 6 days a week fractionated Radiotherapy in Cervical…
CTRI/2023/06/054226 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2023/06/054226 |
|---|---|
| Public title | 5 days a week versus 6 days a week fractionated Radiotherapy in Cervical Carcinoma |
| Scientific title | Accelerated versus conventionally fractionated Radiotherapy in Cervical Cancer: A Prospective study - Nil |
| Primary sponsor | Prof Dr Sunil Choudhary |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified |
| Interventions | Intervention1: Concurrent Chemoradiotherapy followed by Brachytherapy: 45Gy in 25#, 1.8Gy per #, 6# per week over 4.1 weeks followed by ICR or ISBT Control Intervention1: Concurrent Chemoradiotherapy followed by Brachytherapy: 45Gy in 25#… |
| Registration date | Jun 21, 2023 |
| Target size | 40 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: